PPA
VYGR icon

Parametric Portfolio Associates’s Voyager Therapeutics VYGR Stock Holding History

Parametric Portfolio Associates’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,000
Closed -$62K – 3667
2021
Q2 		$62K Buy
+15,000
New +$68K ﹤0.01% 3523
2020
Q1 		– Sell
-33,996
Closed -$474K – 4022
2019
Q4 		$474K Sell
33,996
-62,194
-65% -$904K ﹤0.01% 3381
2019
Q3 		$1.66M Buy
+96,190
New +$2.02M ﹤0.01% 2755

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parametric Portfolio Associates's VYGR Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Voyager Therapeutics (VYGR) in Q3 2021, closing a stake of 15,000 shares — an estimated $62K sold.

Parametric Portfolio Associates first reported a position in VYGR in Q3 2019 and held it in 3 quarters. The position peaked at $1.66M in Q3 2019. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining Voyager Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 15,000 Voyager Therapeutics shares in Q3 2021, an estimated $62K.
  • Parametric Portfolio Associates first reported a position in Voyager Therapeutics in Q3 2019 and held it in 3 quarters.
  • Parametric Portfolio Associates's Voyager Therapeutics position peaked at $1.66M in Q3 2019.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.